Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2024-01-01–present
Proxy statement
Recorded roles and earnings-call appearances connecting this person to public companies.
CEO, Board Member
2024-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Recursion Pharmaceuticals, Inc. (RXRX) | current Chief Executive Officer and President | $600,000 | $5,349,065 |
| 2024 | Recursion Pharmaceuticals, Inc. (RXRX) | Chief R&D and Chief Commercial Officer | $285,000 | $9,194,805 |
Earnings-call appearances and filed executive appointments or departures, newest first.
